Key Benefits

• It is a broad-spectrum, quinolone bactericidal agent
  
  
• It inhibits bacterial deoxyribonucleic acid synthesis and is bactericidal.
  
  
• It is rapidly absorbed following oral administration.
  
  
• It has activity against a broad range of gram-positive and gram-negative aerobic bacteria.
  
  

Indications

• Upper and lower, complicated and uncomplicated, acute and chronic urinary tract infections.
  
  
• It include cystitis, pyelitis, pyelonephritis, chronic prostatitis
  
  
• urinary infections associated with urological surgery, neurogenic bladder or nephrolithiasis caused by bacteria susceptible to norfloxacin